Top Markets
Coin of the day
Intellipharmaceutics International Inc. Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.

IPCI
Classifica tra le azioni #37527
Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998,... Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998, is a pharmaceutical company that focuses on the research, development, and manufacturing of innovative and generic controlled-release and targeted-release oral solid dosage medications, primarily for the United States market. The company leverages its patented Hypermatrix technology to create advanced drug delivery systems, an array of product candidates, and a robust pipeline across diverse therapeutic areas, including neurological, cardiovascular, gastrointestinal, diabetes, and pain management conditions. Its current product portfolio includes extended-release formulations like Focalin XR for hyperactivity disorder, Keppra XR for partial onset seizures, Effexor XR to treat depression, and Protonix for gastroesophageal reflux disease. Other offerings feature Glucophage XR for type 2 diabetes, Seroquel XR for schizophrenia and mood disorders, Lamictal XR for epilepsy, Pristiq for depression, Coreg CR for heart failure and hypertension, and Ranexa for chronic angina. Furthermore, Intellipharmaceutics is actively developing additional controlled-release drugs such as OxyContin for pain relief and Regabatin XR for neuropathic pain management. The company operates under a license and commercialization agreement with Par Pharmaceutical Inc.
Prezzo delle azioni
$0.05897422
Ultima sincronizzazione: 2024-04-02
Capitalizzazione di mercato
$1.64M
Variazione (1 giorno)
0.07%
Variazione (1 anno)
0.00%
Paese
CA
Scambia Intellipharmaceutics International Inc. (IPCI)

Categoria

Storico del prezzo dell'azione per Intellipharmaceutics International Inc. (IPCI)
Prezzo di chiusura più alto: $0.06 il 2024-04-01

Prezzo di chiusura più basso: $108.45 il 1999-07-01
Storico del prezzo dell'azione di Intellipharmaceutics International Inc. dal 1999 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 -19.21%
2023 -6.77%
2022 -35.88%
2021 -17.93%
2020 -60.79%
2019 54.36%
2018 -96.89%
2017 -71.72%
2016 33.05%
2015 -17.01%
2014 -27.24%
2013 48.60%
2012 -20.02%
2011 12.66%
2010 50.99%
2009 2,041.93%
2008 -95.88%
2007 -44.10%
2006 -83.20%
2005 -58.91%
2004 -17.52%
2003 183.96%
2002 -52.99%
2001 -20.32%
2000 53.90%
1999 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE